account_id none on file
legal_name Alterity Therapeutics Ltd
ticker ATHE
cik 1131343
domain alteritytherapeutics.com
linkedin_company_url https://www.linkedin.com/company/alterity-therapeutics/
entry_point_account_id none on file
name Alterity Therapeutics Limited
exchange Nasdaq
sector Health Care
hq Melbourne, Australia
sector index/company/sector/health-care/
calls 0 filings 6 executives 3 family 0
why_nownone on file
callsnone on file
filings
Abby Macnish Niven was appointed as Chief Financial Officer for our Group in September 2024 and as Company Secretary in November 2024.
filing / Aug 28, 2026 / receipt
The continuing viability of the Group is subject to its ability to raise additional capital to finance the continuation of its planned research and development programs, maintaining implemented cost containment and deferment strategies, and successfully commercializing its initiatives.
filing / Aug 28, 2026 / receipt
The continuing viability of the Group is subject to its ability to raise additional capital to finance the continuation of its planned research and development programs, maintaining implemented cost containment and deferment strategies, and successfully commercialising its initiatives.
filing / Aug 28, 2026 / receipt
David Stamler | 65 | Chief Executive Officer and Managing Director
filing / Aug 28, 2026 / receipt
Ann Cunningham | 58 | Director
filing / Aug 28, 2026 / receipt
Abby Macnish Niven | 44 | Company Secretary and Chief Financial Officer
filing / Aug 28, 2026 / receipt
executives
| Abby Macnish Niven | Company Secretary and Chief Financial Officer | - | receipt |
| Ann Cunningham | Director | - | receipt |
| David Stamler | Chief Executive Officer and Managing Director | - | receipt |
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
slug alterity-therapeutics-limited
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$